CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020

• DOI: 10.1093/neuonc/noad149
• Publication Date: 2023-10-04T19:49:13Z
• Authors: Quinn T Ostrom; Mackenzie Price; Corey Neff; Gino Cioffi; Kristin A Waite; Carol Kruchko; Jill S Barnholtz-...
• Keywords: Brain tumor; Histopathology

Abstract The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with Centers for Disease Control and Prevention National Cancer Institute, is largest population-based registry focused exclusively on primary brain other central nervous system (CNS) tumors (US) represents entire US population. This report contains most up-to-date data available supersedes all previous CBTRUS reports terms completeness accuracy. All rates are age-adjusted using 2000 standard population presented per 100,000 average annual incidence rate (AAAIR) malignant non-malignant CNS was 24.83 (malignant AAAIR=6.94 AAAIR=17.88). overall higher females compared to males (27.85 versus 21.62 100,000) non-Hispanic persons Hispanic (25.24 22.61 100,000). Gliomas accounted 26.3% tumors. commonly occurring histopathology glioblastoma (14.2% 50.9% tumors), common predominantly meningioma (40.8% 56.2% tumors). Glioblastomas were more males, meningiomas females. In children adolescents (ages 0-19 years), 6.13 There 86,030 deaths attributed between 2016 2020. an mortality 4.42 17,206 year. five-year relative survival following diagnosis a tumor 35.7%, 91.8%.